Proposal to list medical devices supplied by Geistlich Pharma New Zealand Limited
Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by Geistlich Pharma New Zealand Limited (“Geistlich”) in Part III of Section H of the Pharmaceutical Schedule from 1 March 2023.
We propose to list medical devices supplied in the following category:
Consultation closes at 4pm Tuesday 7 February 2023 and feedback can be emailed to email@example.com.
What would the effect be?
From 1 March 2023 the above medical devices would be listed under proposed national agreements for all Te Whatu Ora Hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreement”).
The Agreement would not be for sole supply and Te Whatu Ora Hospitals can continue to purchase other suppliers’ brands of dental and oral health products.
The Agreements would supersede any existing Te Whatu Ora agreements with Geistlich, for products included in the Agreement. Any products listed in the Agreement and purchased by a Te Whatu Ora would be in accordance with the terms and conditions, including price, stated in the Agreement, effective from the date of listing in the Pharmaceutical Schedule.
As part of the Agreement Geistlich would provide appropriate training and education services that would be tailored to the individual needs of Te Whatu Ora Hospitals, in formats and at times as required by Te Whatu Ora Hospitals. Pricing for the medical devices in the Agreement, subject to any prior termination, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Te Whatu Ora staff including but not limited to:
- Dental Hubs
- Mobile Schools
- Community Dental Clinics
- Suppliers and wholesalers
About the medical devices
Dental and oral health
The dental and oral health category includes medical devices used in dental settings in Te Whatu Ora hospitals for the management of dental and oral health.
Why we’re proposing this
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFP, and proposals were progressed to contract negotiations, to seek provisional agreements.
This proposal is the latest to arise from this process and we expect to consult on further provisional agreements with the suppliers of dental and oral health products throughout 2023.
Details about our proposal
Pharmac has entered into a provisional agreement with Gestlich for the supply of dental and oral health products.
The proposal would result in listing 57 medical devices in the Pharmaceutical Schedule covering the following product ranges:
Dental and oral health products
Medipac, ReOss, Meta and Geistlich range
Further information, including pricing and contractual details, has been provided to Te Whatu Ora Procurement personnel. Clinicians interested in further detail on what this change means for their Te Whatu Ora Hospital should engage with their Procurement teams.
To provide feedback
Send us an email: firstname.lastname@example.org by 4pm 7 February 2023.
All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.